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ABSTRACT Using spectroscopic methods, we have studied the structural changes induced in both protein and DNA upon
binding of the High-Mobility Group I (HMG-I) protein to a 21-bp sequence derived from mouse satellite DNA. We show that
these structural changes depend on the stoichiometry of the protein/DNA complexes formed, as determined by Job plots
derived from experiments using pyrene-labeled duplexes. Circular dichroism and melting temperature experiments extended
in the far ultraviolet range show that while native HMG-I is mainly random coiled in solution, it adopts a -turn conformation
upon forming a 1:1 complex in which the protein first binds to one of two dAdT stretches present in the duplex. HMG-I
structure in the 1:1 complex is dependent on the sequence of its DNA target. A 3:1 HMG-I/DNA complex can also form and
is characterized by a small increase in the DNA natural bend and/or compaction coupled to a change in the protein
conformation, as determined from fluorescence resonance energy transfer (FRET) experiments. In addition, a peptide
corresponding to an extended DNA-binding domain of HMG-I induces an ordered condensation of DNA duplexes. Based on
the constraints derived from pyrene excimer measurements, we present a model of these nucleated structures. Our results
illustrate an extreme case of protein structure induced by DNA conformation that may bear on the evolutionary conservation
of the DNA-binding motifs of HMG-I. We discuss the functional relevance of the structural flexibility of HMG-I associated with
the nature of its DNA targets and the implications of the binding stoichiometry for several aspects of chromatin structure and
gene regulation.
INTRODUCTION
The High-Mobility Group I (HMG-I/Y) proteins are low-
molecular-mass (10.7–11.7 kDa) nonhistone chromosomal
proteins that bind to the minor groove of AT-rich DNA
without clear sequence specificity (Bustin and Reeves,
1996; Salomon et al., 1986) and recognize noncanonical
DNA conformations such as four-way junctions (Hill and
Reeves, 1997). HMG-I/Y contains three DNA-binding do-
mains, consisting of 9–10 basic residues, called AT hooks
(Bewley et al., 1998, and references cited therein), which
are separated by linkers of variable lengths, as well as a
short C-terminal acidic domain.
HMG-I was first identified as a factor associated with the
-satellite heterochromatin sequences of the green monkey,
where it may play a role in nucleosome phasing (Strauss and
Varshavsky, 1984). HMG-I binding sites have also been
characterized in the related mouse -satellite repeats. These
intrinsically curved sequences also contain multiple binding
sites for HMG-I, the distribution of which has been com-
pared to known nucleosome phases characterized in vitro
(Radic et al., 1987, 1992; Martinez-Balbas et al., 1990;
Linxweiler and Ho¨rz, 1985; Carrera et al., 1991; Reeves and
Wolffe, 1996). More recently, HMG-I was proposed to play
a role in the modulation of chromatin structure and acces-
sibility by antagonizing histone H1 binding to AT-rich
scaffold/matrix-associated regions (SARs/MARs) (Zhao et
al., 1993; Strick and Laemmli, 1995). It has also been
shown to have important functions in the formation of
multiprotein complexes, enhancesomes, that regulate the
transcription of several genes (Thanos and Maniatis, 1995;
Bonnefoy et al., 1999; Du et al., 1993; Mantovani et al.,
1998; Yie et al., 1999). Indeed, a number of cytokine genes,
such as -interferon, interleukin-2 receptor -chain, inter-
leukin-4 receptor, as well as herpes and human papilloma
viral genes, are regulated by HMG-I (Thanos and Maniatis,
1995; John et al., 1995, 1996; Kelin-Hessling et al., 1996;
French et al., 1996; Kinioshita et al., 1996; Leger et al.,
1995). Finally, HMG-I is a critical cellular factor required
for the formation of functional HIV-1 preintegration com-
plexes (Li et al., 1998; Farnet and Bushman, 1997), possibly
reflecting its role in promoting the assembly of biologically
active nucleoprotein complexes. HMG-I is abundant in eu-
karyotic nondifferentiated cells and in embryos (Bustin and
Reeves, 1996; Chiappeta et al., 1996; Amirand et al., 1998),
and elevated levels of the protein have been correlated with
neoplastic transformation (Holth et al., 1997; Bandiera et
al., 1998).
The diverse functions that can be inferred for HMG-I in
heterochromatin organization and nucleosome phasing, in
the modulation of chromatin structure and in the formation
of specialized transcriptional complexes, all ultimately de-
pend on its binding to DNA. Some of these functions might
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be related to protein-mediated structural alterations in the
DNA helix, and previous studies have focused on the in-
duction or reversal of DNA bends by HMG-I/Y and on the
possibility of inter- or intramolecular cooperative interac-
tions involving multiple AT hooks (Yie et al., 1997; Maher
and Nathans, 1996; Falvo et al., 1995; Chase et al., 1999;
Lehn et al., 1988; Nissen and Reeves, 1995). However, the
nature and the stoichiometry of the complexes that can be
formed on a potentially broad set of binding sites have not
been studied in detail and remain poorly understood.
We have addressed this question by characterizing the
structural changes that are induced in both protein and DNA
when HMG-I binds to a DNA fragment of defined sequence
and by determining how these changes vary with the stoi-
chiometry of the nucleoprotein complexes that are formed.
The results of our studies are consistent with the induction,
upon HMG-I binding to DNA, of large conformational
changes in the protein that are coupled to relatively small
changes in the structure of the DNA duplex, in agreement
with the induced-fit model proposed by Record (Spolar and
Record, 1994). We present evidence that HMG-I is capable
of forming multiple discrete complexes with DNA in which
the protein structure varies. The protein conformation and
its binding modes are highly sensitive to small changes in
DNA sequence, suggesting that HMG-I mainly recognizes
DNA structural properties and/or flexibility. Finally, a pep-
tide corresponding to an extended AT-hook motif (Reeves
and Nissen, 1990; Geierstanger et al., 1994; Evans et al.,
1995) forms ordered DNA aggregates, a property not shared
by the full-length protein, which can be fitted by molecular
modeling to energetically favorable structures. We discuss
the biological implications of our findings in the light of our
recent results showing that both HMG-I and ATX promote
the onset of zygotic transcription in early mouse embryos
(Beaujean et al., manuscript submitted for publication).
EXPERIMENTAL PROCEDURES
Materials
Succinimidyl-1-pyrenebutyrate, phosphoramidites, and aminolink 2 re-
agents were purchased from Molecular Probes and Applied Biosystems.
Unlabeled oligonucleotides (Oligold) and high-performance liquid chro-
matography-purified fluorescein- and rhodamine-labeled oligonucleotides
were supplied by Eurogentec. All chemical reagents used were of the
highest commercially available purity. The solutions contained 10 mM
buffer at pH 7.2 and 50 mM NaCl unless otherwise stated. Piperazine N,
N-bis(2-ethanesulfonic acid) (PIPES) was used in most experiments. For
thermal denaturation experiments, a cacodylate buffer was used instead
because of its lower absorbance. Identical Tm values were obtained at 259
nm with the two buffers.
Oligonucleotides and peptide
The synthesis and purification of the oligonucleotides labeled at their 5
end with pyrene (Py) were performed as described (Mohammadi et al.,
1997). The fluorescein and rhodamine labels were linked to the oligonu-
cleotides via a hexamethylene (C6) linker. All oligonucleotides were
precipitated in ethanol in the presence of NaCl and desalted using Millipore
Ultrafree filters with a molecular weight cutoff of 5000. The fluorescein-
and rhodamine-labeled oligonucleotides were then extensively washed and
reconcentrated in water, using Millipore filters to eliminate all traces of
free label. The 21-base (D21, C21) and 39-base (D39) oligonucleotides
used in our studies are described in Fig. 1; Py-labeled 11-mers and 21-mers
mutated at the AAAT site, which were also used in this work, have the
following sequences:
(Py)-11A: 5 (Py) TAA AAA ACG TG 3
(Py)-11T: 5 (Py) CAC GTT TTT TA 3
(Py)-21A1: 5 (Py) ACG AGC GCA CTA AAA AAC GTG 3
(Py)-21T1: 5 (Py) CAC GTT TTT TAG TGC GCT CGT 3
The preparation of purified recombinant HMG-I protein was performed
as described (Strick and Laemmli, 1995). Protein concentrations were
measured by the bicinchoninic acid method as described by the manufac-
turer (Pierce Chemical Company), using solutions of bovine serum albu-
min and myoglobin as standards. Alternatively, HMG-I concentrations
were determined using   2.15  105 and 8  104 M1 cm1 in
cacodylate and PIPES buffers at 206 and 217 nm, respectively, but these
measurements are reliable only above 1.5 M because the protein readily
adsorbs on the cell walls in the absence of DNA.
The ATX peptide (YGRPKKPRGRPKKGRPKK) was synthesized on
an Applied Biosystems (Foster City, CA) 430A synthesizer on HMP resin
(Bachem, France). Amino acid side chains were protected by the use of
fluorenylmethyloxylcarbonyl (Fmoc) amino acid chemistry. The purity of
the peptide (98%) was assessed by high-performance liquid chromatog-
raphy (Applied Biosystems 131A) on an Aquapore RP300 column (220/4.6
cm). The integrity of the peptide was further checked by electrospray
ionization, using a Finnegan TSQ 700 mass spectrometer, with an observed
monoprotonated molar mass of 1971.1 (expected: 1971.4).
Melting temperature determination
Tm measurements were performed using a Kontron 942 spectrophotometer.
The temperature within the cell was measured with a temperature sensor.
The melting profiles were monitored at 259, 211, and 222 nm and first
corrected for baseline fluctuations by subtracting the absorbance at the
same wavelength of a matched cell filled with buffer. Experiments at 211
and 222 nm require thorough monitoring of the apparatus response because
the intensity of the deuterium lamp is lower than at 259 nm, and the buffer
probably contributes to the absorbance. To do this, the melting profiles of
the free DNA duplexes were taken as references and measured at all
wavelengths. Any differences between the melting profiles recorded in the
far UV, normalized relative to those monitored at 259 nm, were taken as
corrections. This procedure was required at wavelengths below 210 nm.
Thermal denaturation profiles of protein/DNA complexes were corrected
for the contribution of DNA melting to the total absorbance, using the ratio
of the absorption in the far UV relative to that at 259 nm (measured at
10°C) and the melting of the same DNA solution monitored at 259 nm.
Duplexes were heated to 70°C for 20 min then gently cooled to 10°C and
maintained at this temperature overnight before measurement. The melting
curve derivatives were obtained with Origin 3.5 software.
Circular dichroism
Circular dichroism (CD) was measured at 25°C in a Jasco J-710 spectropo-
larimeter, using a 2-nm bandwidth. CD spectra were averaged over eight
scans at 100 nm/min to improve the signal-to-noise ratio. A 0.05-cm
path-length quartz cell was used in most cases.
Fluorescence measurements
Fluorescence measurements were performed using a QuantaMaster QM-1
PTI instrument equipped with a Hamamatsu R928 photomultiplier and a
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thermostatted cell holder. The data collected were corrected for lamp
fluctuation, photomultiplier response, and buffer signal. Py-labeled oligo-
nucleotides were usually excited at 348 nm with em 360–600 nm, using
2.2- or 3.3-nm slits at the excitation and emission monochromators. Rho-
damine-labeled duplexes were excited at 545 and 560 nm, em  560/
570–700 nm, while fluorescein-labeled duplexes were excited at 480 and
490 nm, em  490/500–700 nm. 2.2-nm slits were used in both cases.
Samples were prepared for FRET measurements at the acceptor side by
dividing into two halves a solution of the rhodamine-labeled strand and
adding either the unlabeled or fluorescein-labeled complementary strand,
yielding equimolar concentrations of the two strands. Likewise, samples
for FRET measurements at the donor side were prepared from the same
fluorescein-labeled oligonucleotide solution to obtain the duplexes carry-
ing single or double labels. In addition, FRET measurements from the
donor side in the absence of protein were performed with samples prepared
differently, as previously described (Toth et al., 1998). The absorbance of
the solutions was below 0.04 at the excitation wavelength, thus avoiding
inner filter effects. Fluorescence yields were measured using quinine
sulfate in 0.1 N sulfuric acid and fluorescein in 0.1 N NaOH as standards
(IUPAC, 1986; Sjo¨back et al., 1995). The oligonucleotides were denatured
and renatured as described above, and the complete hybridization of the
two strands was assayed by melting temperature measurements. A concen-
trated stock solution of HMG-I was added stepwise to these DNA duplex
solutions.
Data analysis
The efficiency of Fo¨rster energy transfer E between a donor and an
acceptor at a distance R is defined as E  1/[1  (R/R0)
6]. R0 is the critical
distance (expressed in Å) at which E 0.5, R0
6 (8.79 1023)n4 2 DJ,
where n is the refractive index of the medium (taken to be 1.4), 2 is the
orientation factor, D is the quantum yield of the donor in the absence of
acceptor, and J is the overlap integral between the emission of the donor
and the absorption of the acceptor. When energy transfer occurs, the
rhodamine (acceptor) emission intensity increases, while that of fluorescein
(the donor) simultaneously decreases. The efficiency of energy transfer
was calculated from the enhanced acceptor emission and decreased donor
emission in three different ways, as follows (Clegg et al., 1993; Jares-
Erijman and Jovin, 1996; Toth et al., 1998).
1. The fluorescence spectrum FDA(490, em) of a doubly labeled sample
with both fluorescein and rhodamine excited at 490 nm can be fitted by the
sum of the two spectral components: the fluorescein emission (singly
labeled duplex with fluorescein excited at 490 nm, FD(490, em)) and the
enhanced rhodamine emission due to energy transfer (a fraction, ratio A, of
the signal obtained by direct excitation of the rhodamine at   560 nm):




 FDA560, em		 .
The coefficient a and the ratio A are determined by the fitting procedure.
Because rhodamine is also excited directly, albeit to a small extent, at 490
nm, its contribution to the total fluorescence FDA (490, em) is subtracted
before the fit. This direct excitation of the acceptor is obtained from the
excitation spectrum of the duplex labeled only with rhodamine. The ratio
A is related to the energy transfer efficiency as follows:




FIGURE 1 Sequences of the D21, C21, and D39 DNA duplexes. Underlined nucleotides represent HMG-I binding sites (Radic et al., 1992; the 5 and
3 HMG-I binding sites on the A-rich strand of D21 are arbitrarily referred to in the text as AAAT and A6, respectively, and the numbers are those used
in molecular modeling. The position of the labels via a C6 linker to the DNA is schematized by lines. Py stands for pyrene, F for fluorescein, and iR or
R for (internal) rhodamine. Each pyrene-linked duplex carries a single label. The sequences of other oligonucleotides used are given in the Experimental
Procedures.
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where A and D are extinction coefficients of the donor and the acceptor
at a given wavelength, determined from the absorption spectra of the
doubly and singly labeled samples.
2. The intensity FDA of the emission of fluorescein in the presence of
rhodamine relative to FD, the emission intensity of a duplex carrying a
single fluorescein label, is directly related to the energy transfer efficiency
E by E  ED  1  FDA/FD. This measurement is straightforward but
relies strongly on the presence of identical donor concentrations in both
singly and doubly labeled duplexes.
3. The transfer efficiency was also calculated from the normalized ratio
of the donor to acceptor emission as defined by Jovin (Jares-Erijman and
Jovin, 1996). Briefly, EDA is calculated from emission measurements only:
E  EDA  1/(1  (A/D)  RDA), where RDA is the ratio of the
fluorescein- to the rhodamine-enhanced emission intensity in the doubly
labeled duplex, each of the two terms being normalized by the correspond-
ing emission spectra of the singly labeled duplexes, and A and D are the
fluorescence yields of the acceptor and the donor, respectively.
Molecular modeling
Molecular modeling was performed with the JUMNA (junction minimiza-
tion of nucleic acids) program (Lavery et al., 1995). In JUMNA, the
efficiency of minimization is improved by the use of helicoidal and internal
variables. Individual 3 nucleotides are positioned with respect to a refer-
ence axis system, using helicoidal variables, and their internal flexibility is
described by both torsion and valence angles, all bond lengths being fixed.
Junctions between successive nucleotides are ensured by quadratic penalty
functions. JUMNA uses the Flex force field (Lavery et al., 1995), which is
specifically designed for modeling of nucleic acids. Electrostatic damping
due to aqueous solvent and counterions is represented by a sigmoidal
dielectric function used in calculating electrostatic energy (with a slope of
0.356 and a plateau of 78) and a reduction of the net phosphate charges.
The ATX peptide studied here was constructed with a standard geom-
etry in both an extended conformation and several more compact confor-
mations containing turns. The turns were positioned by scanning the
peptide sequence for the tetramer probabilities of  and  turns as given
by Wilmot and Thornton (1990). Eleven conformations corresponding to
highest probabilities were constructed and docked with DNA.
Conformations of DNA oligomers, both free and complexed with the
ATX peptide, were analyzed using Curves (Lavery and Sklenar, 1989).
This program makes it possible to calculate an optimal helical axis (quan-
titatively describing the curvature of DNA fragment), along with a full set
of helicoidal parameters.
RESULTS
We have studied the interaction of HMG-I with a DNA
fragment (between nucleotides 187 and 207) derived from
the mouse -satellite repeats that corresponds to one of the
largest curvature peaks found in these repeats (Carrera et al.,
1991). This 21-bp duplex (D21) contains two AT-rich
HMG-I binding sites (Radic et al., 1992): a short AAAT
sequence and an A6 tract (Fig. 1). These two sites are
separated by 9 bp, close to the ideal phasing required, so
that they lie on the same face of the DNA helix. Another
duplex, C21, located downstream from the D21 sequence,
was also used because it presents similar A-T stretches but
in the reverse orientation compared to D21.
The D21 duplex was 5-end-labeled with pyrene, the
fluorescence of which is sensitive to DNA conformation,
thus enabling us to monitor the stoichiometry of HMG-I/
DNA complexes. Alternatively, the duplex was tagged with
rhodamine and fluorescein, allowing us to probe for asso-
ciated structural changes in the DNA by FRET measure-
ments (Fig. 1). Finally, we performed circular dichroism
and melting experiments to detect conformational changes
in the protein induced by DNA binding. Most experiments
were performed with both HMG-I and a short synthetic
peptide, ATX (Amirand et al., 1998; Beaujean et al., 2000),
which corresponds to an extended binding domain of the
protein (1.5 AT hooks), to characterize those changes de-
pendent on the presence of the three DNA-binding domains
of HMG-I and/or of the linkers separating them. Results of
these experiments are presented below.
1. Denaturation profiles of D21 in the presence of
HMG-I and ATX
We first determined the melting profiles of free and bound
DNA as a rough measure of the interaction between the
protein or the peptide and the duplex. Fig. 2 A shows the
melting curves of D21 in the absence or presence of HMG-I
or ATX. As shown in Fig. 2 B, the HMG-I-bound duplex
was stabilized relative to free D21 (Tm 13.5 0.5°C) in
the presence of about one HMG-I molecule per DNA du-
plex. Higher HMG-I concentrations did not increase the Tm
further (Table 1). In contrast, the thermal stabilization of
D21 by the ATX peptide was more modest (Tm  10.0 
0.5°C) and required the presence of a large excess of pep-
tide (Fig. 2 B).
2. HMG-I and ATX/DNA complex formation
monitored by pyrene fluorescence
We sought to characterize HMG-I binding to D21 further by
taking advantage of pyrene fluorescence to determine the
stoichiometry of the complex(es) formed between DNA and
HMG-I or the ATX peptide. Pyrene is a sensitive probe of
DNA structure and of local polarity (Rippe et al., 1992;
Koenig et al., 1977; Kierzek et al., 1993; Ebata et al., 1995;
Mohammadi et al., 1997), and its fluorescence properties
might reveal structural changes induced in the DNA by
binding of HMG-I. Pyrene should not perturb the duplex
because it is uncharged and HMG-I indeed induces a similar
stabilization of pyrene-labeled and unlabeled DNA du-
plexes (see Fig. 2 B).
The D21 target DNA contains two distinct binding sites
for HMG-I. By linking a pyrene label either at the 5 end of
the A-rich strand close to the AAAT site or at the 5
extremity of the complementary T strand, in the vicinity of
the A6 site, one should be able to distinguish HMG-I bind-
ing at each of the two sites in the duplex. We designed two
different labeled duplexes, each carrying a single pyrene
(Py) probe, dPy-21A2 and dPy-21T2. The positions of the
labels are diagrammed in Fig. 1, and the fluorescence prop-
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erties of the Py-labeled duplexes and single-stranded oligo-
nucleotides are summarized in Table 2.
Stoichiometry of the HMG-I/DNA and
peptide/DNA complexes
As shown in Fig. 3 A, binding of HMG-I to the Py-labeled
duplex leads to a large increase in the pyrene fluorescence
intensity. This large intensity increase makes it possible to
determine the stoichiometry of the protein/DNA complexes
by means of Job plots (Loontiens et al., 1990). To do this,
we kept the sum of [protein]  [duplex] concentrations
constant at 1 M, while varying the [duplex]/[protein] ratio.
At concentrations that largely exceed the dissociation con-
stant(s), each complex is characterized by a linear depen-
dence of the absorbance or the fluorescence on the concen-
tration, and the stoichiometry is indicated by inflection
points.
Fig. 4 A shows a representative Job plot derived from an
experiment using dPy-21A2, where the difference in the
fluorescence intensity of the duplex/HMG-I complexes rel-
ative to free dPyA2 was plotted against the mole fraction of
duplex given by [dPy-21A2]/([dPy-21A2]  [HMG-I]).
Three inflection points can be noted at 0.25  0.02, 0.48 
0.04, and 0.84  0.03 mole fraction of duplex. They cor-
respond to three distinct complexes, the stoichiometries of
which are 3 HMG-I/duplex, 1 HMG-I/duplex, and 1 HMG-
I/5 duplexes, respectively. We obtained comparable re-
sults at higher total concentrations (3 M instead of 1 M),
indicating dissociation constants below the micromolar
range (Table 3).
The results of similar experiments performed with the
ATX peptide are shown in Fig. 4 B. The complexes formed
between 0.1 and 0.3 mole fraction of duplex scatter light,
introducing some dispersion in the experimental points and
a larger uncertainty for the first inflection point. This point,
at 0.25  0.05 mole fraction of duplex, corresponds to 3–4
ATX/duplex. The light-scattering properties of this complex
are consistent with the formation of aggregates evidenced
by the fluorescence data (see below and Section 4). The
second inflection point can be more precisely ascertained at
0.50  0.03 mole fraction of duplex and corresponds to a
1:1 peptide/duplex complex, a stoichiometry identical to
that of one of the three complexes formed with full-length
HMG-I.
Comparison of the 5 and 3 HMG-I binding
sites of the duplex
As noted above, these experiments, which make it possible
to determine the stoichiometry of the protein/DNA com-
plexes, can also be used to ask whether the two binding sites
present in the duplex participate equally and/or simulta-
neously in complex formation. Fig. 3 A compares the pyrene
fluorescence intensity at 378 nm in the presence of HMG-I
relative to the free dPy-21A2 and dPy-21T2 duplexes. Both
titration curves reach a plateau at a HMG-I/DNA ratio of
3–4, but their I/I0 limits differ. These curves also differ, at
low HMG-I concentrations, by a more rapid increase of the
dPy-21A2 fluorescence relative to dPy-21T2.
Fig. 3 B presents a similar comparison of dPy-21A2 and
dPy-21T2, this time in the presence of the ATX peptide. The
increase in pyrene fluorescence was smaller with the pep-
tide than with the protein. A very different response was
again observed as a function of the position of the label:
binding of the peptide to dPy-21A2 yielded a very small
increase in the fluorescence at 378 nm, whereas a sharp
transition was observed for dPy-21T2 above 3 ATX peptide
equivalents. Surprisingly, at the same peptide concentration,
we observed the appearance of a pyrene excimer character-
ized by a broad emission at 490 nm (Fig. 3 B, inset). This
excimer was absent when dPy-21A2 was used (Table 2 B).
We verified that these results were not due to nonspecific
binding and/or aggregation: in experiments performed in the
presence of spermine (up to 12 mM), we could not observe
FIGURE 2 Melting profiles of D21 in the absence or presence of
HMG-I. Melting curves are shown in A. Melting of the D21 duplex was
monitored at 259 nm in the absence or presence of 1 HMG-I equivalent
(solid and dashed lines, respectively). (B) The variation of the Tm 
Tm(D21bound)  Tm(D21free) as a function of HMG-I/DNA or peptide/
DNA ratios. Experiments were carried out under the following conditions:
[Duplex]  0.8 M, 10 mM cacodylate buffer (pH 7.2), 50 mM NaCl. f,
unlabeled D21; F, duplex with the Py-21A2-labeled strand in the presence
of HMG-I; Œ, D21 in the presence of the ATX peptide.
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changes in pyrene fluorescence intensity or excimer forma-
tion with dPy-21T2 (data not shown).
The presence of an excimer can only result from the close
proximity, within 3–5 Å, of at least two DNA duplexes,
each carrying a single pyrene label and in parallel orienta-
tion relative to one another (Mohammadi et al., 1997, and
references therein). If both parallel and antiparallel duplex
orientations were possible, one should then observe an
excimer with dPy-21A2, which is not the case. These results
could thus be explained if the duplexes are organized by the
peptide in a parallel orientation starting from a common
origin, the A6 binding site present in the duplex, before
diverging at distances greater than 5 Å toward the AAAT
binding site.
To verify this hypothesis, we synthesized and tested
pyrene-labeled 11-mer duplexes, dPy-11A and dPy-11T,
bearing only the A6 binding site of the original 21-mer (see
Experimental Procedures). Results of these experiments are
summarized in Table 2. Addition of the ATX peptide at a
concentration of 1 mM induced aggregation of the 11-mer
duplexes, with the formation of a large excimer on dPy-11T,
similar to that obtained with dPy-21T2. In contrast to dPy-
21A2, binding of the peptide to dPy-11A led to an excimer
formation, but of half the intensity of the dPy-11T one, as
expected if the duplexes diverge from a common origin
located at the A6 binding site (Table 2 B).
Taken together, our fluorescence data strongly suggest
that the complexes formed at high effector/D21 ratios differ
in the presence of HMG-I from those observed with the
ATX peptide. The latter can induce a supramolecular orga-
nization of the duplexes into ordered aggregates, which
probably results from the vectorial binding of ATX to DNA.
This conclusion is supported by the results of molecular
modeling experiments presented below.
3. Structural changes induced in DNA by binding
of HMG-I measured by FRET
FRET has been widely used to determine the distance
between chromophores bound to a relatively rigid structure,
with numerous applications to the fields of nucleic acid
structure and protein-DNA interactions (Gohlke et al., 1994;







Tm at 259 nm
(1°C)
— 2–8‡ — (20) 60–65 1–4 —
— 13-50ATX§ — (18) 60 1–3 —
0.67 2 3 (18) 62.7 7–8 69.9
1.33 2 1.5 66.7 16 70.2
2¶ 2 1 70 30 70.2
0.67 — 55.8 55.8
2 57.1 57.1
Results of thermal denaturation experiments performed in 10 mM cacodylate buffer (pH 7.2) and 50 mM NaCl are summarized for D21, HMG-I, and
D21/HMG-I complexes.
*Values shown correspond to the maxima of the derivative, assimilated to the Tm, while numbers in parentheses refer to shoulders in the curve derivative.
†The amplitude is equal to 100  (A80-A10)/A10, where A10 and A80 represent the absorbance at 10°C and 80°C, respectively, monitored at 211 nm.
The melting curves were corrected by subtracting the DNA contribution at this wavelength for solutions containing both HMG-I and DNA (see
Experimental Procedures).
‡Similar Tm values were obtained at 222 nm at HMG-I concentrations ranging from 4 to 16 M.
§Note that high peptide concentrations were required to yield conditions comparable to those used with HMG-I in units of peptide bonds.
¶Higher DNA concentrations could not be used at constant [HMG-I] because of excessive total absorbance and the large contribution of the DNA relative
to that of the bound protein.
TABLE 2 Fluorescence properties of free and HMG-I- or
ATX-bound pyrene-labeled duplexes
Labeled
strand  single strand*  duplex*  duplex-HMG-I* I/I0
†
A. Labeled duplexes / HMG-I
Py-21A2 2.0  10
2 4.2  103 1.1  102 (3.0  0.1)
Py-21T2 2.7  10




B. Labeled duplexes/ATX complexes
Py-21A2 (1.40  0.05) 0
Py-21T2 (2.25  0.07) (0.23  0.01)
(2.4  0.07)§ (0.26  0.01)§
Py-21T1 (3.2  0.1) (0.16  0.01)
Py-11A1 (1.45  0.05)§ (0.08  0.01)§
Py-11T1 (5.4  0.2)§ (0.21  0.1)§
Experiments were performed in 10 mM PIPES buffer (pH 7.2) and 50 mM
NaCl at T  25°C, except where noted§ where T  20°C; samples were
excited at   348 nm, using 2 or 3-nm excitation and emission slits.
Measured values are shown for free and HMG-I-bound pyrene-labeled
duplexes (A) while the properties of ATX-bound labeled DNA are sum-
marized in B.
*The quantum yields were calculated relative to quinine sulfate   0.545
in 0.1 N H2SO4 (IUPAC, 1986). The error on the values is 6%.
†I/I0 is the ratio of the pyrene fluorescence intensity measured at   378
nm in the presence of a large excess of HMG-I relative to that of the free
duplex.
‡Ratio of pyrene excimer to monomer intensities at 490 and 378 nm,
respectively, in the presence of a large excess of ATX peptide.
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Clegg et al., 1993; Eis and Millar, 1993, Mergny et al.,
1991; Jares-Erijman and Jovin, 1996; Heyduk et al., 1997;
Toth et al., 1998). We used FRET to compare interchro-
mophore distances in the absence or presence of HMG-I,
using fluorescein and rhodamine as the donor and acceptor,
respectively. Rhodamine was either linked to T11 or T20 of
the A-rich strand, while fluorescein was introduced at the 5
or 3 end of the complementary strand. This defines three
donor-acceptor distances (see Fig. 1). The first donor-ac-
ceptor pair flanks the short AAAT site (iRF3), the second
one spans the long A6 site (iRF5), and the third one is close
to the end-to-end distance of the duplex (RF3).
We first verified the feasibility of using these labeled
DNA molecules. Control experiments showed that the in-
ternal rhodamine label at T11, although it slightly modified
the CD spectrum relative to the unlabeled duplex, yielded a
comparable difference spectrum (see Fig. 7 A and data not
shown). In addition, the labeling did not change the thermal
FIGURE 3 Fluorescence changes induced in Py-labeled duplexes by HMG-I and ATX. Conditions are the same as those described in Fig. 2, except that
PIPES buffer was used instead of cacodylate. D21 duplexes were labeled with pyrene on either strand (see Fig. 1) and equilibrated with increasing amounts
of HMG-I (A) or ATX (B). The fluorescence intensity I measured at 378 nm is normalized to that obtained with the free pyrene-labeled duplex I0. In each
panel, dPy-21A2 is represented by circles, dPy-21T2 by squares. The insets show fluorescence spectra of the free (bottom curves), HMG-I-bound dPy-21A2
and ATX-bound dPy-21T2 duplexes (upper curves) excited at 348 nm.
FIGURE 4 Job plots of Py-labeled D21 in
the presence of HMG-I or ATX. Job plots of
dPy-21A2 in the presence of HMG-I are
shown in A. Fluorescence signals were ob-
tained using [duplex]  [HMG-I]  1 M,
exc  348 nm, and em  378 nm. (B)
[duplex] [ATX]  1 M. Absorbance
changes were monitored at 259 nm. Note
that because ATX induces small fluores-
cence changes at low concentrations, the ab-
sorbance is more sensitive to changes in the
stoichiometry. 10 mM PIPES buffer (pH
7.2), 50 mM NaCl.
Induced Fit of HMG-I upon Binding to DNA 2549
Biophysical Journal 78(5) 2543–2559
stabilization of the three labeled duplexes by HMG-I rela-
tive to D21 (data not shown). Thus the introduction of the
chromophores does not perturb the duplex-HMG-I interac-
tions, validating FRET as a tool for the study of local DNA
structural changes induced by HMG-I binding.
Energy transfer efficiency E is calculated from the en-
hanced acceptor emission EA, the decreased donor fluores-
cence ED, and the ratio of donor to acceptor EDA (Clegg et
al., 1993; Jares-Erijman and Jovin, 1996; Toth et al., 1998).
Fig. 5 A shows plots of E as a function of added HMG-I, in
which each point was derived from the values of EA, ED,
and EDA calculated from two independent measurements,
with an error of 0.01 (see Experimental Procedures). We
first examined changes in energy transfer for the donor-
acceptor pair spanning the AAAT site: upon addition of
HMG-I to the duplex, the efficiency increased from 0.47 to
0.56 in the presence of two protein molecules per DNA,
then leveled off. In contrast, the energy transfer for the
donor-acceptor pair spanning the A6 site first reached an
apparent plateau at a ratio of two HMG-I per DNA, then
leveled off at three HMG-I equivalents. Finally, the end-to-
end donor-acceptor pair first exhibited an energy transfer
increase after the addition of one HMG-I equivalent, fol-
lowed by another increase between two and three HMG-I
molecules added per duplex.
The resulting donor-acceptor distances are shown (Fig. 5
B); they correspond to the data of Fig. 5 A, using a random
orientation factor 2  0.66 and R0  51.7 Å which
corresponds to a mean value, obtained for RF3, iRF3, and
iRF5, ranging between 50.7  0.4 and 52.7  0.4 Å in the
absence and presence of a large HMG-I excess relative to
DNA, respectively. These results show that the interchro-










[dPy21A2]  [HMG-I]  1 M 0.25  0.02 3–4
0.55  0.04 0.48  0.04 1
0.82  0.03 0.84  0.03 0.2
[dPy21T2]  [HMG-I]  3 M 0.24  0.02 3
0.50  0.04 1
0.77  0.03 0.3
[dPy21A2]  [ATX]  1 M 0.22  0.04 0.18  0.04 3–4
0.50  0.03 0.50  0.03 1
[dPy21T2]  [ATX]  4 M 0.17  0.04 6–7
0.25  0.05 0.25  0.05 3
0.50  0.03 0.50  0.03 1
Experiments were performed in 10 mM PIPES buffer (pH 7.2) and 50 mM NaCl.
*Absorption changes monitored at 259 nm.
†Fluorescence changes recorded at 378 nm upon excitation at   348 nm, using 2-nm slits.
FIGURE 5 Fluorescence energy transfer ob-
served in the presence of HMG-I. (A) Transfer
efficiency E as a function of the HMG-I/DNA
ratio. Each point represents the average of EA,
ED, and EDA values from two experiments using
the different duplexes described in Fig. 1. iRF3
is represented by circles and iRF5 by squares
(left scale). RF3 is represented by crosses (right
scale). (B) Corresponding distances, using R0 
51.7 Å and 2  0.66 (random orientation).
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mophore distance spanning the short AAAT site decreases
by up to 3.5 Å in the presence of HMG-I, whereas the
distance corresponding to the longer A6 site decreases by
only 2.5 Å. Correspondingly, the donor-acceptor pair sep-
arated by the 19 base pairs that span the two binding sites is
brought 6.0  0.8 Å closer in the presence of excess
HMG-I. This holds true at protein/DNA ratios of 3:1 to 4:1,
corresponding to the formation of the 3:1 protein/DNA
complex. The 1:1 complex is characterized by a small
distance change, R  1.5 Å, at the AAAT binding site
(iRF3), while the A6 site (iRF5) undergoes a negligible
change compared to the protein-free duplex. The donor-
acceptor pair spanning the two binding sites (RF3) yields
an distance change of R  1.7 Å, corroborating this
assignment.
These results show that the two binding sites contained in
the DNA fragment used are not equivalent and that the
shorter AAAT site is occupied by HMG-I first. HMG-I
increases the intrinsic curvature and/or shortens the length
of the 21-mer duplex upon formation of the 3:1 complex.
4. Structural modifications revealed by
CD spectroscopy
Free protein and peptide
We sought additional evidence for conformational changes
induced in both HMG-I and the DNA duplex upon forma-
tion of the different complexes described above. To do this,
we first analyzed the CD spectra of the protein in the
absence of DNA. Free HMG-I and the ATX peptide both
exhibit a strong negative band at 200 nm and a shoulder
around 225 nm (Fig. 6 A, spectrum a, and data not shown).
The intensity of the ellipticity was proportional to protein
concentration, suggesting that the protein is monomeric in
the 4–25 M concentration range. Finally, the HMG-I
spectrum did not show the typical CD signature of an
-helix, even in the presence of 10% trifluoroethanol, a
conformation possibly precluded by the proline and glycine
residues of the AT hooks (Kentsis and Sosnick, 1998; Tan
and Frankel, 1995). The HMG-I CD spectrum fitted a
random-coil content of 73  6% and a -turn content of
27 6%. This fit should be considered together with the Tm
data presented below.
HMG-I/DNA complexes
The CD spectrum of the D21 duplex is characterized by
peaks at 280 and 220 nm and a negative band at 249 nm,
characteristic of DNA in B conformation (Fig. 6 A, spec-
trum b). The interaction of HMG-I with the D21 duplex
occurs in two distinct steps (Fig. 6 A, bottom panel). An
isoelliptic point is observed at 264 nm. A difference spec-
trum can be calculated by subtracting the sum of the free
HMG-I and duplex spectra from that measured for the 1:1
FIGURE 6 CD spectra of free and bound D21,
HMG-I, and ATX peptide. Experiments were performed
in PIPES buffer as described above. The CD spectra of
HMG-I (16 M, spectrum a, right scale), D21 (16 M,
spectrum b, left scale), and HMG-I/D21 (16 M each,
spectrum c, left scale), are shown in the upper part of A.
The spectra are normalized to an optical path length l 
1 cm. The spectra of free D21 (16 M, spectrum d) or
D21 complexed with ATX (48 and 60 M, spectra e
and f, respectively) are shown in the upper part of B
(normalized to l  1 cm). The lower part of each panel
shows the ellipticity obtained at selected wavelengths as
a function of HMG-I or ATX equivalents added. In A,
measurements at 205 nm are denoted by filled circles
(left scale), and asterisks and open diamonds correspond
to   249 and 280 nm, respectively (right scale). In B,
asterisks and open diamonds represent measurements
taken at 249 and 280 nm, respectively. The lower panels
have been normalized to l  1 cm.
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HMG-I/D21 complex: this difference spectrum yields a
positive peak at 200–205 nm with a shoulder around 220
nm (Fig. 7 A, spectrum a). By comparison with standard
spectra (Yang et al., 1986), this peak is consistent with a
20–40% increase of the -turn content compared to the free
protein. Note that the difference spectra obtained at HMG-
I/DNA protein ratios above 1.5 had a smaller amplitude than
at the 1:1 ratio (data not shown).
We next asked whether binding of HMG-I to DNA might
depend on the length of the DNA used and/or on the
sequence of its two HMG-I binding sites. To address this
question, we repeated our experiments, using two different
DNA fragments, C21 and D39 (Fig. 1). C21 corresponds to
a 21-bp duplex located downstream of the D21 sequence in
the mouse satellite repeats. It also contains two HMG-I
binding sites but gives rise to a single uninterrupted HMG-I
footprint, in contrast to the two distinct footprints reported
for D21 (Radic et al., 1992). D39 corresponds to a longer
39-bp fragment that contains the D21 and C21 sequences in
tandem, allowing us to compare the formation of HMG-I/
DNA complexes on different binding sites, analyzed in-
dividually or when they are present on the same DNA
molecule.
Fig. 7 A shows a comparison of the  difference spectra
obtained from C21 and D21. In the absorption range of
DNA, the difference spectrum of the C21/HMG-I complex
(curve b) is comparable to that observed with D21 (curve a).
However, in the 200–220-nm range, the ellipticity changes
in the complexes formed with D21 and C21 are markedly
different. This difference is consistent with the hypothesis
that the complexes formed by HMG-I with D21 and C21 are
distinct, as already suggested by footprinting analysis. In-
terestingly, the difference spectrum of D39 in this region is
similar to that of C21 at HMG-I/DNA ratios close to 1:1 but
resembles that of D21 at the higher protein/DNA ratio (Fig.
7, compare A and B). However, in the DNA region, the 
values obtained with D39 are much larger than those ob-
tained in the presence of D21. Finally, the plot of the
ellipticity values at 249 nm as a function of the HMG-I/
DNA ratio shows two transitions (see Fig. 7 B, inset). These
results suggest that HMG-I first binds to the C21 sequence
before binding to the D21 sequence in the larger D39 duplex
containing both.
Taken together, these results are consistent with a struc-
turing of the protein upon DNA binding. Analysis of the CD
spectra shown here indicates that this induced structuring
occurs in parallel to conformational changes in the DNA
duplex and depends upon the protein/DNA ratio as well as
on the duplex sequence and length, that is, on the nature of
the binding sites present in the DNA. This latter conclusion
is confirmed by the results of melting experiments presented
in Section 5.
ATX/D21 complexes
We also compared the complexes formed by the ATX
peptide with D21. Based on the results presented above, the
structure—or lack thereof—of ATX resembles that of full-
length HMG-I. A comparison of spectra d and e of Fig. 6 B
shows that, qualitatively, binding of the peptide yields
changes in the structure of the D21 duplex that are similar
to those induced by full-length HMG-I. However, we did
not observe, in the peptide absorption region, a difference
spectrum similar to that shown in Fig. 7 A for the full-length
protein. The presence of a large excess of peptide relative to
D21 induced an inversion and a shift of the 280-nm band, as
well as a decrease in the negative 249-nm and positive
225-nm bands (Fig. 6 B, spectrum f). High concentrations of
FIGURE 7 Difference CD spectra of HMG-I bound to different DNA duplexes. Experimental conditions are as described in the legend to Fig. 6. (A) One
equivalent of HMG-I bound to 16 M D21 (spectrum a) or C21 (spectrum b). The  spectra of D39 (16 M) at HMG-I/DNA ratios of 1.2 (spectrum
d) and 2.75 (spectrum c) are shown in B; the inset shows the ellipticity values of D39/HMG-I complexes monitored at 205 (circles, right scale) and 249
nm (squares, left scale) as a function of the protein concentration.
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spermine or of polylysine, as well as basic peptides derived
from histone H1, are known to produce an inversion of the
280-nm band, which was attributed to the formation of 
aggregates (Khadake and Rao, 1997; Bailly et al., 1993;
Erard et al., 1990; Maestre and Reich, 1980; Gosule and
Schellman, 1978). Although the amplitude of the negative
signal reported in these cases is much larger than that
observed with the ATX peptide, it is likely that the peptide,
which carries 10 positive charges, induces DNA aggrega-
tion when present at concentrations close to those required
to neutralize the negative charges of the D21 duplex. These
results are thus in excellent agreement with the fluorescence
data showing the appearance of an excimer, indicative of a
supramolecular organization of the DNA duplex induced by
binding of ATX (Fig. 3 B), as modeled in Section 6.
5. Melting profiles of free HMG-I, ATX peptide,
and HMG-I bound to D21
The results of the CD experiments presented above suggest
that HMG-I is most likely largely unstructured in solution
but undergoes structural changes upon formation of a com-
plex with duplex DNA. To determine whether this is indeed
the case, we performed melting experiments extended into
the far ultraviolet range, where light absorbance is mainly
due to the protein. At 10°C, HMG-I displays an absorption
peak at max  206 nm in cacodylate buffer. At 80°C, this
maximum is red-shifted to 211 nm, and a decrease in the
absorbance parallels this max shift. We made use of this
phenomenon to monitor possible structural modifications of
HMG-I upon heating in the absence or presence of DNA
and at different protein/DNA ratios (see Experimental Pro-
cedures). We obtained fully reversible denaturation profiles
of free and DNA-bound HMG-I.
As shown in Fig. 8, free HMG-I presents a weak absorp-
tion transition at 60°C. This transition is independent of
the HMG-I concentration in the range tested (2–16 M) and
therefore most likely corresponds to an intramolecular fold-
ing-unfolding process. We also measured the thermal dena-
turation of the ATX peptide. Within the limits of experi-
mental error, the peptide melting curve was identical to that
of the full-length protein.
In contrast, the extent of protein denaturation was larger
in the presence of DNA and, in this case, strongly dependent
on the protein/DNA ratio. At a 1:1 protein/DNA ratio (curve
b in Fig. 8 and see below), the derivative of the denaturation
curve of the bound protein showed a sharp peak at 70°C,
10°C higher than the free protein, with small inflections
near 50° and 65°C. The presence of these apparent shoul-
ders indicates that the thermal denaturation of HMG-I does
not follow a simple two-state model. Consequently, the
corresponding van’t Hoff values of H and S could not be
calculated. Results of these experiments, which are summa-
rized in Table 1, also show a decrease of the Tm value when
the protein/DNA ratio is increased. This suggests that the
protein molecules present in excess relative to DNA are less
structured than the first HMG-I equivalent that is bound.
Our results show that the denaturation/renaturation of
both the DNA duplex and the protein are fast relative to the
time scale of these experiments. Free HMG-I is as struc-
tured (or unstructured) as the ATX peptide. Binding of the
protein to the DNA duplex stabilizes both protein and DNA
against thermal denaturation. The markedly different melt-
ing profiles obtained at protein/DNA ratios ranging from
1:1 to 3:1 clearly show that this transition is dependent on
the binding stoichiometry, in agreement with the assign-
ments based on our measurements of changes in pyrene
fluorescence upon formation of these complexes (Figs. 3
and 4).
6. Molecular modeling of ATX complexes formed
with D21 and C21
While the complexes we propose for the interactions be-
tween HMG-I and ATX with DNA are based on the exper-
imental data, an important question is whether they corre-
spond to energetically plausible molecular models. We
therefore carried out a molecular modeling study based on
the JUMNA (junction minimization of nucleic acids) pro-
gram (Lavery et al., 1995; see the Experimental Procedures
for details). The HMG-I protein is too unstructured to en-
FIGURE 8 Melting curves of free and DNA-bound HMG-I. Melting
curves (A) and corresponding curve derivatives (B) are shown for the free
protein (a) or for the protein bound to D21 (b–d). The absorbance was
monitored at 211 nm, where both HMG-I and DNA absorb, and corrected
for DNA absorption as detailed in the Experimental Procedures. Melting
profiles were determined at HMG-I/DNA ratios of 1:1, 1.5:1, and 3:1
(curves b, c, and d, respectively). Conditions are as described in Fig. 2.
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able us to carry out a reliable modeling study. Although the
ATX peptide represents a simpler case, its lack of secondary
structure when uncomplexed again makes modeling diffi-
cult. We have therefore focused our study on the confor-
mational aspects of its complexes with DNA. From an
energetic point of view it is possible to compare different
locations of the ligand bound to DNA as well as different
ligand orientations, the energy of the free ligand being a
constant term that can be ignored. We were primarily in-
terested in determining whether the difference observed in
the interaction of the peptide with the two distinct DNA
oligomers, D21 and C21, had its origin in qualitative con-
formational differences between these two sequences.
The energy-minimized conformations of the two free C21
and D21 oligomers were found to be very similar, exhibiting
all the features of a classical B-DNA conformation. Both
sequences have an average rise of 3.4 Å and an average
twist of 37°, and all of the sugars are positioned in the
southern region. There are, however, small differences in
helicoidal parameters correlated with the two sequences:
base pair inclination is stronger in the vicinity of GC bases
pairs, and a strong propeller (10°-30°) is seen for AT bases
pairs. Both oligomers are only weakly curved: 17° in the
case of D21 and 26° for C21.
ATX/D21complex
The most energetically favorable complex obtained for the
ATX peptide bound to D21 is presented in Fig. 9 A. In
agreement with the preference observed experimentally, the
peptide is located on the minor groove side of the A6 tract.
This location is significantly more stable than for complexes
formed on the AAAT site, though the latter is the preferred
binding site for the protein. The geometry of the optimized
complex is similar to that of the HMG-I(Y) binding domain
bound to the PRDII sequence studied by Huth et al. (1997).
In particular, we found the same orientation of the peptide
with respect to DNA. Our calculations show that this ori-
entation is favored by both electrostatic and van der Waals
interaction energies. The complex shown in Fig. 9 A is
stabilized by several hydrogen bonds between the peptide
and atoms of bases in the minor groove at A14(N3),
A15(O1), and T34(O2), as well as by a series of hydrogen
bonds between the anionic oxygens of phosphates 11, 12,
14, 16, and 18 and the cationic side chains of lysines and
arginines belonging to ATX. The peptide does not follow
the axis of the DNA minor groove, but rather stays on one
side of the double helix, also contacting the anionic oxygens
of phosphates 17 and 18 on the major groove side. The
internal conformation of the peptide is also stabilized by
intrapeptide hydrogen bonds of the 1–3 type at its C-termi-
nal end (Arg-8–Arg-10, Lys-12–Lys-14, and Pro-16–Pro-
18). Complexation by the ATX peptide does not introduce
important conformational changes in the D21 oligomer: its
average rise and twist are unchanged, while its curvature
increases only very slightly to 24°.
ATX/C21 complex
In contrast, the lowest-energy complex formed by ATX on
C21 has a different location. In this case, the ATX peptide
is shifted toward the middle of the oligomer, reaching out to
both the AAAT and A5T sequences. The energy of this
complex is weaker than that formed with the D21 sequence.
The peptide stays on the outside of the double helix without
forming hydrogen bonds to the atoms of the bases, and the
curvature of DNA remains unchanged (28°). It is difficult to
explain this difference in peptide location, which might be
due to a small increase in the curvature of C21 oligomer or,
more probably, to differences in the flexibility and in the
electrostatic potential and field distributions associated with
this particular sequence. While the basis for this difference
will have to be addressed in future studies, the model shown
in Fig. 9 B is consistent with the single uninterrupted
HMG-I footprint obtained with the C21 sequence (Radic et
al., 1992), in contrast to D21.
A model for the ATX/DNA nucleated complex
We also addressed the question of whether an energetically
favorable model might account for the induction of ordered
condensation of DNA duplexes by ATX. In this case, the
observation of a pyrene excimer suggests that ATX binding
to DNA is directional. JUMNA modeling indeed shows that
the formation of a complex with two parallel DNA oli-
FIGURE 9 Optimal models for the ATX/D21 and ATX/C21 complexes.
The energetically most favorable complexes were modeled as detailed in
the Experimental Procedures. The ATX/D21 and ATX/C21 complexes are
shown in A and B, respectively. The DNA backbone is colored in blue, AT
base pairs in red, and GC base pairs in yellow. The ATX peptide is colored
in green.
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gomers joined by a single ATX peptide represents an ener-
getically reasonable structure that does not require signifi-
cant DNA deformations. As shown in Fig. 10, the two DNA
oligomers are oriented in a parallel manner and brought
together by the ATX peptide bound at the 5 end of the
T-rich strands. In this complex, interactions with the first
DNA molecule are almost unchanged, and all of the hydro-
gen bonds between the ATX peptide and D21 observed in
the 1:1 complex are preserved. The same peptide now forms
five additional hydrogen bonds to the second DNA oli-
gomer. Formation of this complex does not require impor-
tant structural adaptations. The first helix is only slightly
modified at its 5 end, and its curvature remains unchanged
at 17°. The second helix is somewhat more deformed at the
end that contacts the ATX peptide, and its curvature is
increased to 37°.
DISCUSSION
Our work establishes several aspects of HMG-I and ATX
structure in solution and upon binding to a short DNA
sequence derived from the mouse -satellite repeats that
constitute a natural binding site for the protein. We show
that HMG-I is capable of undergoing conformational
changes as a result of DNA binding. These structural
changes depend on the stoichiometry of the HMG-I/DNA
complexes formed and on the sequence of the DNA target
as detailed below. In contrast, HMG-I or ATX binding
induces only minor changes in DNA conformation. We also
discuss the relevance of these properties to the functions of
HMG-I in vivo.
1. Free HMG-I is mainly unstructured
The very small amplitude of the protein melting curve
shows that, in the absence of DNA, HMG-I is mainly
unstructured (Fig. 8). In addition, the CD spectrum of
HMG-I is best fitted by 73% random coil and 27% in
-turn, the latter probably corresponding to one or more of
its AT hooks. Thus the inter-AT hook domains of the
full-length protein are probably random-coiled, a conclu-
sion consistent with the suggestion that “in the absence of
DNA, the NMR spectrum of HMGI(2/3) (a truncated
HMG-I containing two AT hooks) is indicative of random-
coiled” (Huth et al., 1997), while a peptide corresponding to
one HMG-I AT hook adopts turn-like conformations (Evans
et al., 1995).
As our work identifies distinct HMG-I/DNA complexes
that differ in their stoichiometries and in the sequences
bound, we discuss first the characteristics of each of these
complexes before analyzing the structural changes their
formation imparts on the protein.
2. HMG-I and the ATX peptide form different
complexes with the target sequences
HMG-I forms three distinct complexes with the DNA target
used: 3:1 and 1:1 protein/DNA complexes and a 1:3–1:5
complex at micromolar concentrations. Preliminary gel re-
tardation assays confirm the existence of 1:1 and 3:1 com-
plexes (data not shown). 1:1 HMG-I/DNA complexes have
been reported at low (pM-nM) concentrations (Maher and
Nathans, 1996; Reeves and Nissen, 1990). A complex
formed by one truncated HMG-I(2/3) molecule per two
DNA duplexes has also been reported (Huth et al., 1997).
The ATX peptide forms two types of complexes with D21.
The first one has a 1:1 stoichiometry and the second one
consists of aggregates. Aggregates were reported for an AT
hook-derived peptide (Geierstanger et al., 1994), although a
single complex was observed with the binding-domain pep-
tide of Reeves and Nissen (1990).
The 1:1 DNA/protein or DNA/peptide complex
Both HMG-I and ATX both form a well-defined 1:1 com-
plex with DNA, but their respective binding modes depend
on the target sequence, D21 or C21. While previous work
has shown that a single HMG-I molecule can simulta-
neously contact two sites in the interferon- promoter and
in synthetic sequences (Yie et al., 1997; Maher and Nathans,
FIGURE 10 A model for the ATX/D21 parallel complex. The complex
shown is modeled as described in the legend to Fig. 9. The DNA backbone
is colored in blue, AT base pairs in red, and GC base pairs in yellow. The
ATX peptide is colored in green. The angle between the two D21 helices
is 45°. The structure obtained accounts for the formation of an ordered
2:1 DNA/ATX complex with two molecules of D21 in parallel orientations
and is fully consistent with the presence of the pyrene excimer.
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1996), our results indicate that this property can be con-
strained by the DNA sequence.
HMG-I and ATX bind to a single site of D21. Our FRET
experiments show that, in the 1:1 complex, HMG-I mainly
occupies the 5-most AAAT binding site of D21, which,
although shorter than the A6 tract, was indeed predicted to
be optimal for HMG-I binding (Huth et al., 1997). Under
these conditions, a 21-mer duplex mutated in this site shows
an immediate increase of the fluorescence of the Py label
linked at the end of the A6 binding site relative to the
“delayed” response in 21-dPyT2, where the pyrene is at-
tached at the same end (Fig. 4 A and data not shown). This
elicits no intramolecular cooperative binding of HMG-I AT
hooks to these two sites in the 1:1 complex. The ATX
peptide also binds to a single site of D21. The larger and
earlier fluorescence increase of dPyT2 compared to dPyA2
(Fig. 3 B) suggests that, in this complex, the A6 sequence is
favored by ATX over the AAAT binding site, in agreement
with the molecular model shown in Fig. 9.
ATX occupies both AT-rich sites of C21, as reported for
HMG-I. Our results show that the complexes formed by
HMG-I on D21 and C21 are different (Fig. 7 A), in agree-
ment with footprinting data (Radic et al., 1992; see Fig. 1).
ATX follows the same trend: in contrast to its location in the
minor groove of D21 (Fig. 9 A), ATX remains on the
outside of the C21 duplex and reaches out to both the
AAAT and A5T binding sites (Fig. 9 B). This may reflect
the differences in the intrinsic curvature of D21 and C21
(17° and 26°, respectively), which probably depends on the
relative position of the longer A6 or A5T site with respect to
the shorter AAAT one. It seems unlikely that the distance
between the two sites, which is similar in D21 and C21,
drives these different binding modes (Maher and Nathans,
1996). One possibility is that the two duplexes reach the
same final curvature upon formation of the 1:1 complex, in
which case the formation of the complex with D21 would be
accompanied by a greater deformation or structuring of the
protein than when the complex is formed with C21. While
it is fully consistent with our CD data, this hypothesis, the
corollary of which is that HMG-I recognizes mainly DNA
structural properties and/or flexibility, requires additional
experimental support.
Large modification of protein structure coupled to minor
DNA structural changes upon 1:1 complex formation. Our
melting experiments show that both the extent of denatur-
ation and the Tm of DNA-bound HMG-I are markedly
increased in the 1:1 complex. In parallel, the CD difference
spectra observed in the 190–215-nm window, where the
protein contributes most of the signal, are similar to that
reported for a peptide presenting a type I -turn (Rag-
hothama et al., 1998). NMR studies of a truncated HMG-I
sequence show that the second AT hook forms a type II
-turn in the minor groove of the DNA (Huth et al., 1997).
Thus the spectroscopic changes associated with formation
of the 1:1 complex are likely to arise from a restructuring of
the DNA-binding domains of the native protein into a
-turn conformation. In contrast to the large change in
protein structure observed upon complex formation, the
conformation of the D21 oligonucleotide is only slightly
modified, as shown by the results of FRET experiments
(R  1.7 Å).
The 3:1 multiprotein/DNA complex
Our study is the first documenting the formation by HMG-I
of a single multiprotein/DNA complex with a 3:1 protein/
DNA stoichiometry. This complex corresponds to DNA-
mediated protein-protein (self) interactions. Protein-protein
contacts involving HMG-I have been demonstrated with the
bZip and Ets domains of ATF2 and Elf-1 and in the en-
hancesome (Thanos and Maniatis, 1995; Du et al., 1993;
Mantovani et al., 1998; John et al., 1995, 1996). Our FRET
data are best explained by the binding of the third HMG-I
equivalents to the longer A6 tract. The location of the
second protein molecule is less evident because FRET ef-
ficiencies are affected at both sites (Fig. 5). A small increase
in DNA bending and/or a compaction of the double helix
(R  4.7 Å) is associated with HMG-I binding in this
complex. This effect is very small compared to the curva-
ture induced by other DNA-binding proteins such as TBP or
SRY (Bewley et al., 1998, and references cited therein). In
the silencer of the -globin gene, binding of HMG-Y results
in bending of the DNA (Chase et al., 1999), while it reverses
the intrinsic DNA bend of the interferon- enhancer (Falvo
et al., 1995). We suggest that HMG-I binding may induce or
reverse DNA bending, depending on the sequence context
and on the stoichiometry of the complexes formed.
Formation of the 3:1 complex is reflected by a decrease in
the CD difference spectrum and in the amplitude and Tm of
the protein melting transition (Fig. 8 and data not shown).
These differences relative to the 1:1 complex suggest that
two of the three HMG-I molecules associated with the 3:1
protein/DNA complex are likely to be much less structured
than the first HMG-I equivalent bound. Alternatively, they
might adopt different conformations. This new finding of a
change in HMG-I structure as a function of the stoichiom-
etry may explain the sensitivity of the pattern of protection
of poly d(A-T) against OH. cleavage by HMG-I to the
DNA/protein ratio (Franck et al., 1998). Our results suggest
that, rather than possessing a preexisting structure that
might alter that of DNA, HMG-I can instead adapt its
structure upon binding to DNA. This is different from most
other DNA binding proteins, for instance the unrelated
HMG1 protein, which shares with HMG-I its affinity for the
minor groove of AT-rich DNA and its ability to bind to
altered DNA structures and to induce DNA bending (Bustin
and Reeves, 1996; Hill and Reeves, 1997; Bianchi et al.,
1989; Heyduk et al., 1997; Stros, 1998), but has a well-
defined structure in solution (Grosschedl et al., 1994). We
propose that the adaptability—or induced fit—of HMG-I is
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characteristic of an ancillary protein whose binding to dif-
ferent sites might have evolved into different functions.
Indeed, a recent report showed that HMG-I-like architec-
tural factors were functional from early in evolution (Ara-
vind and Landsman, 1998). Depending on the context in
which they are found, the AT hooks of HMG-I-like proteins
might remain independent or interfere with other DNA-
binding domains present in these proteins, which would
allow for cross-talk to occur between the minor and major
grooves of a DNA binding site.
Oriented DNA aggregates formed upon ATX binding
In contrast to the 3:1 HMG-I/DNA complex, ATX forms
organized aggregates on D21, as evidenced by CD and
fluorescence spectroscopy. These aggregates are oriented
and ordered, although the AT-hook motif has been sug-
gested to bind DNA in two orientations (Huth et al., 1997).
The energetically reasonable model of this nucleated struc-
ture shown in Fig. 10 indeed successfully reproduces the
parallel orientation of the two DNA duplexes deduced from
pyrene excimer formation. Formation of this structure,
which is not seen with the use of full-length HMG-I, does
not require important structural changes in the DNA double
helices. It is likely that the inter-AT-hook linkers of HMG-I
and/or its negatively charged C-terminal domain restrict its
binding modes relative to the ATX peptide. Interestingly,
MATH20, an artificial protein containing 20 AT-hook mo-
tifs connected by linkers, condenses chromatin (Strick and
Laemmli, 1995; Girard et al., 1998). This remarkable prop-
erty suggests that the activity of HMG-I-like proteins can be
modulated by the number, spacing, and conformations of
their AT-hook motifs.
These multieffector/DNA complexes differ with ATX
and HMG-I, although both protein and peptide have been
shown to advance the onset of transcription in early mouse
embryos (Beaujean et al., in press). Part of the role of
HMG-I in the regulation of transcription is to facilitate the
formation of multiprotein complexes (Thanos and Maniatis,
1995; Bonnefoy et al., 1999; Du et al., 1993; Mantovani et
al., 1998; Yie et al., 1999). However, the ATX peptide does
not possess C-terminal or linker domains that would allow
the “recruitment” of chromatin remodeling or specific tran-
scription factors, but only an extended AT hook. Thus the
finding that ATX can substitute for HMG-I in one-cell
mouse embryos is somewhat surprising. Our model of ATX
aggregates may provide a clue to this intriguing result. It
suggests that the peptide alters the electrostatic field of the
DNA at specific sites without major structural rearrange-
ments, allowing closer contact between negatively charged
moieties. This may indirectly facilitate protein-protein in-
teractions, even in the absence of a proper protein-binding
domain (Panagiotidis et al., 1995). Alternatively, ATX, like
HMG-I, may displace factors that inhibit transcription.
4. Relevance of the stoichiometry of HMG-I-DNA
complexes to HMG-I function in vivo
An important question is whether the complexes character-
ized in this study can form in vivo. Considerably high local
HMG-I concentrations might be found in the nucleus, and
HMG-I is indeed known to be concentrated in -satellite
repeats. Recently, we have reported the existence of discrete
nuclear populations of HMG-I that are highly concentrated
relative to the bulk of the protein that is distributed fairly
homogeneously within the nucleoplasm (Amirand et al.,
1998). We proposed that these subpopulations might reflect
distinct and separable biological functions of the HMG-I
protein. Furthermore, nucleosome linkers such as those
found in AT-rich satellite DNAs or in scaffold-associated
regions (SAR/MAR sequences) are greatly enriched for
potential HMG-I binding sites. It therefore seems plausible
that formation of higher-order complexes might be favored
in regions of higher HMG-I local concentrations. If so, one
would predict that, under conditions where HMG-I levels
decrease, as in the course of development and differentia-
tion, the equilibrium between lower and higher order com-
plexes would be shifted accordingly. Modulation of HMG-I
levels would thus provide the means to regulate the stoichi-
ometry—and hence the properties—of the complexes
formed at clustered sites—in heterochromatin or at the base of
chromatin loops—or at dispersed binding sites in euchromatin.
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